The first total synthesis of Aeruginazole A, prepared via a convergent strategy that involved both solid-phase peptide synthesis and solution phase chemistry and that enabled conservation of the stereochemistry of the intermediates, is reported.
Aeruginazole A is a macrocyclic dodecapeptide that was recently isolated from the cyanobacterium Microcystis sp. strain and that exhibits inhibitory activity, toward Bacillus subtilis.
1 It is an interesting example of the numerous macrocyclic thiazole-containing compounds that have been isolated from natural sources over the past few decades and subsequently tested for biological activity, and whose extremely varied structures have been the targets of total syntheses. 2 The diverse combination of structural motifs in Aeruginazole A is interesting: its macrocycle comprises a pentapeptide of L-amino acids (known as the northern region) and a group of three thiazole moieties combined with a D-Tyr residue (the southern region).
The presence of L-and D-amino acids, and of amino acid-derived moieties, in the compound is interesting, as is their location: the L-amino acids are located in the western and eastern regions only, whereas there are two consecutive D-amino acids in the southern region. The stereochemistry of the target molecule is therefore an important feature and a critical synthetic challenge. Intrigued by its peculiar structure and seeking to further explore its biological activity, we decided to undertake the total synthesis of Aeruginazole A.
Work began with the retrosynthetic analysis represented in Figure 1 : in addition to the northern pentapeptide 1, tyrosine 3 5 and the optically active thiazole-building blocks 2À4 were identified through disconnections of the southern region of Aeruginazole A (Figure 1) .
The planned route to the stereodefined thiazole building blocks 2À4 was to subject precursor thioamides to Hantzsch thiazole synthesis. These precursors were readily accessed from Boc-L-Asp(OBzl)-OH, Boc-L-Val-OH, and † Institute for Research in Biomedicine. ‡ CIBER-BBN Networking Centre on Bioengineering, Biomaterials, and Nanomedicine.
§ Present address: C atedra de Quı´mica Farmac eutica (DQO), Facultad de Quı´mica, UdelaR, Montevideo, Uruguay. (3) The absence of a protecting group on the Tyr phenol (for which a tBu group is normally used) enabled use of Boc for temporary protection of the R-amino function in the southern region, thereby facilitating the synthesis.
Boc-D-Leu-OH. Commercially available N-protected amino acids were converted into the corresponding primary amides 6aÀ8a (Scheme 1) through activation and subsequent treatment with concentrated aqueous ammonia.
The Leu was activated for nucleophilic substitution through transformation into the corresponding methyl ester. 4 Unfortunately, this easy protocol gave poor yields with Val and was incompatible with the benzyl ester group of protected Asp. Alternatively, these residues were activated by treatment with 2,2,2-trichloroethyl chloroformate. Each of the amides 6aÀ8a was then converted into its corresponding thioamide 6bÀ8b, respectively, using Lawesson's reagent (LR).
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The three thioamides were then subjected to Hantzsch thiazole syntheses, a critical point in the total synthesis, given the need to preserve the stereochemical information present in the thioamides themselves. First, classical conditions for this reaction were tested: the thioamides were treated with ethyl bromopyruvate and pyridine in refluxing ethanol. 6 Optical purity was checked in the case of the known compound Val-thiazole 9 (Scheme 1) by comparison of its rotatory power with published data. However, racemization of Leu-thiazole 10 and Aspthiazole 11 was detected further in the synthetic sequence:
NMR spectra revealed formation of diastereomeric mixtures of products when 10 and 11 were converted into the more advanced synthetic intermediates 13 and 14, respectively (Scheme 3), each of which bears two stereocenters. Once a chiral HPLC analysis method for all three Hantzsch synthesis products had been established, racemization was definitively confirmed (see Experimental Procedures for details, Supporting Information). Switching to Merritt and Bagley's protocol 9 (Scheme 1) for Hantzsch synthesis of stereodefined thiazoles provided the building blocks 9À11 in 75À98% yields with conservation of optical purity (ee ranging from 91 to 94%). It should be noted that special care had to be paid to the dehydration step (Scheme 1, step ii). Lowerthan-expected ee's were observed when the reaction temperature was increased before the dehydration was complete. 
1 H NMR spectra of compounds 13 and 14 were analyzed: singlets falling in the region from δ 8.00 to 8.15 ppm, relative to the protons in position 5 of each thiazole ring, were used as diagnostic signals. Observation of a second set of these signals revealed that substrates of low optical purity were coupled, thus forming mixtures of diastereomeric products. (10) The original paper described direct concentration of the reaction mixtures with consequent trifluoroacetylation of Boc-protected amino groups; an additional transformation was therefore required to remove the trifluoroacetyl groups and provide access to the desired products. This problem was solved by quenching excess TFAA with saturated aqueous NaHCO 3 , providing thiazoles 9À11 directly.
Therefore, termination of the step at À25°C had to be carefully confirmed before the work up. Furthermore, the previously published work-up procedures had to be slightly modified to enable direct access to the desired compounds.
10
Once the Hantzsch products 9À11 were obtained in suitable optical purity, Asp-thiazole 11 was converted into the desired building block 12 (Scheme 2).
The benzyl ester protecting group was cleanly removed by hydrogenolysis; the reaction was first attempted in MeOH but, unexpectedly, partial conversion of the acid to the corresponding methyl ester was observed (from trace amounts up to 53%). This problem was solved by running the reaction in iPrOH, which is more sterically hindered. Acid 11a was then converted into the corresponding amide 12. The conditions for this transformation had to be extensively investigated, since the initially tested activation strategies and NH 3 sources gave low yields. Actually, activation as mixed anhydrides using either Boc 2 O 11 or 2,2,2-trichloroethyl chloroformate and use of alternative NH 3 sources (conc. aq. NH 3 or NH 4 Cl) never gave yields superior to 55%. However, better yields (68%) were obtained when benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) 12 was used as activating agent and ammonium bicarbonate was used as NH 3 source.
The building blocks 9, 10, and 12 were then deprotected. The ethyl ester of 9 was hydrolyzed with 2 N LiOH to give compound 3; the Boc-protecting groups from 12 and 10 were removed with 4 M HCl to afford their corresponding hydrochloride salts 2 3 HCl and 4 3 HCl, respectively (Scheme 3). At this stage, all of the building blocks required for the southern peptide had been synthesized; the preparation of northern peptide was therefore addressed.
Fmoc-protected pentapeptide 1 was smoothly synthesized by solid-phase peptide synthesis (SPPS) on 2-chlorotritylchloride resin, first manually, through activation with diisopropyl carbodiimide and 1-hydroxybenzotriazole (HOBt), then by adapting the procedure to automated microwave-assisted synthesis using O-(benzotriazol-1-yl)-N,N,N 0 ,N 0 -tetramethyluronium hexafluorophosphate (HBTU) as coupling agent.
Since the building blocks 1À4 (Figure 1 ) had been prepared, condensation of the individual synthetic intermediates was then undertaken. The coupling pattern (Scheme 3) was chosen according to the highest possible degree of convergence: Asn-thiazole 2 3 HCl was coupled to Boc-D-Tyr-OH, giving rise to building block 13 (91% yield), whereas D-Leu-thiazole 4 3 HCl was condensed with Val-thiazole 3 to form building block 14 (79% yield). Both couplings proceeded uneventfully (3 h at 0°C) through activation by PyBOP.
The amine 15 was then coupled to the acid 16 to form the tris-thiazole peptide 17. Interestingly, the yield of this reaction was strongly dictated by the ratio of amine to acid: whereas an excess (1.2 equiv) of acid 16 gave a disappointingly low yield (58%), an excess (1.6 equiv) of amine hydrochloride 15 allowed an increase the yield to 92%. The Boc-protecting group was then removed from compound 17 (Scheme 3) to afford the southern peptide 18, which was directly coupled to northern peptide 1. The protocol (PyBOP in THF) used in all previous couplings was again tested but proved unsatisfactory in this case (yields of roughly 10%). Observed solubility issues, as well as a desire to minimize the amount of N,N-diisopropylethylamine (DIEA) used, in consideration of the presence of the Fmoc group, were therefore addressed by switching to a different system, N-(3-dimethylaminopropyl)-N 0 -ethylcarbodiimide hydrochloride (EDCI)/HOBt in CH 2 Cl 2 /DMF, which gave a gratifying yield of 79%. At this stage, the entire linear skeleton of Aeruginazole A had been prepared and thiazole dodecapeptide 19 (Scheme 3) was ready for final hydrolysis of its ethyl ester group, cleavage of its Fmoc group and subsequent macrocyclization. Thus, compound 19 was treated with LiOH in THF/H 2 O in a one-pot removal of the protecting groups on both ends of the peptide to give the acid 20. Macrocyclization of crude 20 was then performed in high dilution conditions (2.5 mM in DMF) by activation with PyBOP and HOAt, affording the desired product in a 24% yield over the two steps of deprotection and cyclization.
The spectroscopic data for this product fully agreed with those for a sample of natural product, thereby enabling confirmation of the structure proposed for Aeruginazole A by Raveh and Carmeli.
1 In summary, Aeruginazole A was obtained in an overall yield of 4.3% through a convergent synthesis combining solution-and solid-phase procedures. Special care was paid to conserve the integrity of the stereocenters in the intermediates, via strict control of Hantzsch thiazole syntheses and through use of various peptide-coupling reagents.
Scheme 2. Synthesis of Asn-thiazole 12
